NCS Testing Technology Co., Ltd.
SZSE:300797.SZ
12.66 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,097.674 | 949.533 | 815.42 | 701.636 | 585.455 | 546.425 | 505.581 | 398.232 | 370.897 | 365.963 |
| Cost of Revenue
| 583.538 | 504.564 | 436.664 | 382.292 | 332.215 | 312.875 | 288.541 | 229.943 | 210.953 | 214.374 |
| Gross Profit
| 514.136 | 444.969 | 378.756 | 319.344 | 253.24 | 233.55 | 217.04 | 168.289 | 159.945 | 151.589 |
| Gross Profit Ratio
| 0.468 | 0.469 | 0.464 | 0.455 | 0.433 | 0.427 | 0.429 | 0.423 | 0.431 | 0.414 |
| Reseach & Development Expenses
| 130.286 | 102.611 | 101.337 | 59.311 | 44.396 | 45.808 | 49.334 | 45.348 | 40.495 | 34.653 |
| General & Administrative Expenses
| 59.805 | 57.949 | 43.369 | 32.44 | 26.462 | 20.426 | 17.025 | 13.001 | 11.096 | 64.276 |
| Selling & Marketing Expenses
| 55.793 | 53.413 | 102.528 | 96.811 | 74.281 | 71.162 | 67.3 | 57.405 | 55.323 | 54.208 |
| SG&A
| 115.598 | 239.463 | 145.897 | 129.251 | 100.743 | 91.588 | 84.326 | 70.406 | 66.42 | 118.484 |
| Other Expenses
| 138.26 | -1.243 | -0.551 | 3.087 | 5.177 | 7.199 | 1.631 | 1.796 | 22.639 | 27.058 |
| Operating Expenses
| 384.145 | 340.831 | 285.646 | 221.536 | 164.481 | 162.234 | 147.541 | 119.038 | 129.569 | 122.068 |
| Operating Income
| 129.991 | 104.137 | 95.688 | 87.763 | 81.551 | 70.849 | 70.304 | 45.601 | 27.737 | 27.652 |
| Operating Income Ratio
| 0.118 | 0.11 | 0.117 | 0.125 | 0.139 | 0.13 | 0.139 | 0.115 | 0.075 | 0.076 |
| Total Other Income Expenses Net
| 0.248 | -0.037 | -0.551 | 3.087 | 5.177 | 7.199 | 1.631 | 1.796 | 22.639 | 27.058 |
| Income Before Tax
| 130.239 | 104.1 | 95.137 | 90.849 | 86.728 | 78.048 | 71.935 | 47.397 | 50.376 | 54.71 |
| Income Before Tax Ratio
| 0.119 | 0.11 | 0.117 | 0.129 | 0.148 | 0.143 | 0.142 | 0.119 | 0.136 | 0.149 |
| Income Tax Expense
| 8.936 | 3.181 | 1.331 | 6.678 | 9.579 | 8.951 | 7.687 | 5.342 | 5.721 | 7.26 |
| Net Income
| 145.022 | 125.697 | 113.842 | 84.192 | 77.22 | 69.136 | 64.227 | 42.05 | 44.667 | 47.488 |
| Net Income Ratio
| 0.132 | 0.132 | 0.14 | 0.12 | 0.132 | 0.127 | 0.127 | 0.106 | 0.12 | 0.13 |
| EPS
| 0.39 | 0.34 | 0.31 | 0.23 | 0.21 | 0.19 | 0.23 | 0.15 | 0.12 | 0.13 |
| EPS Diluted
| 0.38 | 0.33 | 0.31 | 0.23 | 0.21 | 0.19 | 0.23 | 0.15 | 0.12 | 0.13 |
| EBITDA
| 225.24 | 178.846 | 160.039 | 143.368 | 105.142 | 93.665 | 82.675 | 59.455 | 39.813 | 37.778 |
| EBITDA Ratio
| 0.205 | 0.188 | 0.196 | 0.204 | 0.18 | 0.171 | 0.164 | 0.149 | 0.107 | 0.103 |